AstraZeneca’s infringement trial against Pharmacor pushed back

Intellectual Property 2026-05-12 1:12 pm By Julia Kanapathippillai Sydney

Make us a preferred source Make us a preferred source on Google

Trial in AstraZeneca’s patent infringement case over Pharmacor’s plans to launch a cheaper version of diabetes drug Forxiga has been delayed to October, after the generic drug maker got the all-clear to revise its cross-claim.